Publications by authors named "M Dieters"
Proton radiotherapy significantly reduces pneumonia in oesophageal cancer patients.
Int J Radiat Oncol Biol Phys
January 2025
Background: Neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection is the current standard of care for oesophageal cancer (EC) patients. This treatment is associated with a variety of complications, with pneumonia being the most common. We hypothesize that proton radiotherapy (PRT) can significantly reduce the incidence of pneumonia compared to photon radiotherapy (PhRT).
View Article and Find Full Text PDFArticle Synopsis
- Australian wheat breeders access wheat germplasm through the CAIGE program, which coordinates the selection, import, quarantine, and evaluation of this germplasm for the Australian wheat industry.
- The CAIGE model has been validated through trials from 2017 to 2020, showing significant yield improvements from germplasm contributions compared to non-CAIGE varieties.
- Investing in CAIGE has proven highly profitable, offering a benefit-cost ratio of $20 for every dollar spent, indicating substantial economic returns and ongoing benefits for Australian wheat breeding.
A panel of 114 genetically diverse barley lines were assessed in the greenhouse and field for resistance to the pathogen , the causal agent of barley leaf rust. Multi-pathotype tests revealed that 16.6% of the lines carried the all-stage resistance (ASR) gene , followed by (4.
View Article and Find Full Text PDFBackground And Purpose: Neoadjuvant chemoradiotherapy (nCRT) is used in locally recurrent rectal cancer (LRRC) to increase chances of a radical surgical resection. Delineation in LRRC is hampered by complex disease presentation and limited clinical exposure. Within the PelvEx II trial, evaluating the benefit of chemotherapy preceding nCRT for LRRC, a delineation guideline was developed by an expert LRRC team.
View Article and Find Full Text PDFPurpose: In the Netherlands, oesophageal cancer (EC) patients are selected for intensity modulated proton therapy (IMPT) using the expected normal tissue complication probability reduction (ΔNTCP) when treating with IMPT compared to volumetric modulated arc therapy (VMAT). In this study, we evaluate the robustness of the first EC patients treated with IMPT in our clinic in terms of target and organs-at-risk (OAR) dose with corresponding NTCP, as compared to VMAT.
Materials And Methods: For 20 consecutive EC patients, clinical IMPT and VMAT plans were created on the average planning 4DCT.